 |
PDBsum entry 3d25
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
3d25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of ha-1 minor histocompatibility antigen bound to human class i mhc hla-a2
|
|
Structure:
|
 |
Hla class i histocompatibility antigen, a-2 alpha chain. Chain: a. Synonym: mhc class i antigen a 2. Engineered: yes. Beta-2-microglobulin. Chain: b. Fragment: unp residues 22-119. Synonym: beta-2-microglobulin form pi 5.3. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-a, hlaa. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: b2m, cdabp0092, hdcma22p. Synthetic: yes. Other_details: the peptide is commercially synthesized. It is found
|
|
Resolution:
|
 |
|
1.30Å
|
R-factor:
|
0.169
|
R-free:
|
0.204
|
|
|
Authors:
|
 |
S.Nicholls,K.P.Piper,F.Mohammed,T.R.Dafforn,S.Tenzer,M.Salim, P.Mahendra,C.Craddock,P.Van Endert,H.Schild,M.Cobbold,V.H.Engelhard, P.A.H.Moss,B.E.Willcox
|
Key ref:
|
 |
S.Nicholls
et al.
(2009).
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
Proc Natl Acad Sci U S A,
106,
3889-3894.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-May-08
|
Release date:
|
10-Feb-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
106:3889-3894
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
|
|
S.Nicholls,
K.P.Piper,
F.Mohammed,
T.R.Dafforn,
S.Tenzer,
M.Salim,
P.Mahendra,
C.Craddock,
P.van Endert,
H.Schild,
M.Cobbold,
V.H.Engelhard,
P.A.Moss,
B.E.Willcox.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
T cell recognition of minor histocompatibility antigens (mHags) underlies
allogeneic immune responses that mediate graft-versus-host disease and the
graft-versus-leukemia effect following stem cell transplantation. Many mHags
derive from single amino acid polymorphisms in MHC-restricted epitopes, but our
understanding of the molecular mechanisms governing mHag immunogenicity and
recognition is incomplete. Here we examined antigenic presentation and T-cell
recognition of HA-1, a prototypic autosomal mHag derived from single nucleotide
dimorphism (HA-1(H) versus HA-1(R)) in the HMHA1 gene. The HA-1(H) peptide is
restricted by HLA-A2 and is immunogenic in HA-1(R/R) into HA-1(H) transplants,
while HA-1(R) has been suggested to be a "null allele" in terms of T cell
reactivity. We found that proteasomal cleavage and TAP transport of the 2
peptides is similar and that both variants can bind to MHC. However, the
His>Arg change substantially decreases the stability and affinity of HLA-A2
association, consistent with the reduced immunogenicity of the HA-1(R) variant.
To understand these findings, we determined the structure of an HLA-A2-HA-1(H)
complex to 1.3A resolution. Whereas His-3 is accommodated comfortably in the D
pocket, incorporation of the lengthy Arg-3 is predicted to require local
conformational changes. Moreover, a soluble TCR generated from HA-1(H)-specific
T-cells bound HA-1(H) peptide with moderate affinity but failed to bind HA-1(R),
indicating complete discrimination of HA-1 variants at the level of TCR/MHC
interaction. Our results define the molecular mechanisms governing
immunogenicity of HA-1, and highlight how single amino acid polymorphisms in
mHags can critically affect both MHC association and TCR recognition.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Crystallographic structure of HLA-A2-VLH at 1.3Å. (A)
Overall structure of HLA-A2-VLH complex, with heavy chain
(gray), β2m (cyan), and VLH peptide (blue) shown. (B) 2Fo-Fc
electron density for the VLH peptide, with primary anchors and
P3 to P5 highlighted. (C) Structure of the VLH mHag in the
HLA-A2-antigen binding groove, with antigen-binding pockets A to
F indicated, and VLH peptide surface indicated in green. The
structure highlights relatively poor contacts with pockets E and
F. (D) Orientation of H3 in and around the D pocket. H3 packs
snugly against the walls of the D pocket, maintaining van der
Waal's contacts with Tyr-159, Leu-156, and Gln-155, and also to
Asp-4 of the peptide. It is also participates in a
hydrogen-bonding network to Gln-155, and peptide residues Asp-4
and Asp-5, via ordered water molecules. Semitransparent peptide
surface shown in green.
|
 |
Figure 4.
Surface plasmon resonance analysis of TCR/HLA-A2-HA-1
interaction. (A) Specific binding of KP7 TCR to HLA-A2-VLH
(solid line), with control (HLA-B7-TPR) and HLA-A2-VLR signals
also shown (dashed and dotted lines, respectively). (B)
Equilibrium affinity analysis of TCR/HLA-A2-VLH interaction.
Scatchard plot is shown inset.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Bleakley,
and
S.R.Riddell
(2011).
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.
|
| |
Immunol Cell Biol,
89,
396-407.
|
 |
|
|
|
|
 |
Y.Ofran,
H.T.Kim,
V.Brusic,
L.Blake,
M.Mandrell,
C.J.Wu,
S.Sarantopoulos,
R.Bellucci,
D.B.Keskin,
R.J.Soiffer,
J.H.Antin,
and
J.Ritz
(2010).
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
|
| |
Clin Cancer Res,
16,
1642-1651.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|